Prena

Prena is a St. Petersburg, Florida-based medical device company focused on preventing preterm birth. We are dedicated to safeguarding infants by reducing the tragic consequences of premature labor through a novel, non-invasive photo biomodulation approach.

Our core technology utilizes light to down-regulate melatonin secretion, effectively switching off uterine contractions. This innovative method, based on research from the Florida State University College of Medicine, has demonstrated over 70% success in preventing preterm labor in human trials.

Prena’s team, comprised of globally recognized scientists and clinical experts, is committed to advancing clinical trials and bringing this life-saving solution to market. We are currently finalizing product development and preparing for pivotal clinical trials in the US and Europe, with approximately 75% of our funding secured from institutional investors.

We are proud to be recognized as a top solution provider in Gynecology by MedTech and to collaborate with renowned clinicians like Professor Anna David at University College London.